Latest Health News

Tag: seen-at-their

  • UK agency backs cancer drug after Sanofi cuts price

    —

    by

    creative
    in

    LONDON (Reuters) – Britain's healthcare cost watchdog NICE said on Friday it had changed its mind and decided to recommend Sanofi's prostate cancer drug Jevtana after the French company agreed to a further discount. The National Institute for Health and Care Excellence (NICE) said the improved discount was “an excellent example of how pharma companies…

  • UK agency backs cancer drug after Sanofi cuts price

    —

    by

    admin
    in

    LONDON (Reuters) – Britain's healthcare cost watchdog NICE said on Friday it had changed its mind and decided to recommend Sanofi's prostate cancer drug Jevtana after the French company agreed to a further discount. The National Institute for Health and Care Excellence (NICE) said the improved discount was “an excellent example of how pharma companies…

  • Roche says FDA fast tracks atezolizumab in specific type of lung cancer

    —

    by

    admin
    in

    Roche Holding AG said on Monday the U.S. Food and Drug Administration has granted priority review for atezolizumab for treating people with a specific type of lung cancer. The designation covers treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose disease expresses the protein PD-L1 as determined by an FDA-approved…

  • Regeneron, Sanofi eczema drug clears hurdles in big trials

    —

    by

    elegant
    in

    Regeneron Pharmaceuticals Inc and Sanofi said on Friday their experimental treatment for eczema proved highly effective in two large studies, without serious side effects often seen with standard treatments for the chronic inflammatory skin disease. The drugmakers said they would seek U.S. approval this year for their injectable drug, dupilumab, based upon strong results in…